中外医疗
中外醫療
중외의료
China Foreign Medical Treatment
2015年
31期
3-4
,共2页
溃疡性结肠炎%康复新液%中药汤剂
潰瘍性結腸炎%康複新液%中藥湯劑
궤양성결장염%강복신액%중약탕제
Ulcerative colitis%Kangfuxin liquid%Traditional Chinese medicine decoction
目的:探讨溃疡性结肠炎采用康复新液保留灌肠治疗的临床效果。方法整群选取该院消化科在2014年1-12月收治的120例溃疡性结肠炎患者为研究对象,根据治疗方法的选择将其平均分为观察组和对照组,每组60例患者。对对照组患者采取中药汤剂治疗方法,观察组患者则采用康复新液保留灌肠治疗,对比两组患者的治疗效果。结果观察组中显效率为78.4%(47/60),有效率为18.3(11/60),治疗总有效率为96.7%,效果明显优于对照组的38.3(23/60)、46.7%(28/60)以及85.0%,观察组总有效率高于对照组,两组患者结果差异具有统计学意义(P<0.05)。结论采用康复新液治疗溃疡性结肠炎患者,能明显提升治愈率,改善患者的临床症状。
目的:探討潰瘍性結腸炎採用康複新液保留灌腸治療的臨床效果。方法整群選取該院消化科在2014年1-12月收治的120例潰瘍性結腸炎患者為研究對象,根據治療方法的選擇將其平均分為觀察組和對照組,每組60例患者。對對照組患者採取中藥湯劑治療方法,觀察組患者則採用康複新液保留灌腸治療,對比兩組患者的治療效果。結果觀察組中顯效率為78.4%(47/60),有效率為18.3(11/60),治療總有效率為96.7%,效果明顯優于對照組的38.3(23/60)、46.7%(28/60)以及85.0%,觀察組總有效率高于對照組,兩組患者結果差異具有統計學意義(P<0.05)。結論採用康複新液治療潰瘍性結腸炎患者,能明顯提升治愈率,改善患者的臨床癥狀。
목적:탐토궤양성결장염채용강복신액보류관장치료적림상효과。방법정군선취해원소화과재2014년1-12월수치적120례궤양성결장염환자위연구대상,근거치료방법적선택장기평균분위관찰조화대조조,매조60례환자。대대조조환자채취중약탕제치료방법,관찰조환자칙채용강복신액보류관장치료,대비량조환자적치료효과。결과관찰조중현효솔위78.4%(47/60),유효솔위18.3(11/60),치료총유효솔위96.7%,효과명현우우대조조적38.3(23/60)、46.7%(28/60)이급85.0%,관찰조총유효솔고우대조조,량조환자결과차이구유통계학의의(P<0.05)。결론채용강복신액치료궤양성결장염환자,능명현제승치유솔,개선환자적림상증상。
Objective To observe the clinical effect of retention enema with kangfuxin liquid in the treatment of ulcerative colitis. Methods 120 cases with ulcerative colitis admitted in Department of Gastroenterology of our hospital from January 2014 to December 2014 were selected as the subjects and equally divided into the observation group and the control group with 60 cases in each in accordance with the treatment method. Patients in the control group were treated by the traditional Chinese medicine decoction, while those in the observation group were treated by retention enema with kangfuxin liquid. And the treatment effect of the two groups was compared. Results Compared with the control group, the observation group had much higher markedly effective rate [78.4%(47/60) vs 38.3%(23/60)], significantly higher effective rate [18.3%(11/60) vs 46.7%(28/60)], obviously higher overall effective rate (96.7%vs 85.0%), the differences between the two groups were sta-tistically significant (P<0.05). Conclusion Kangfuxin liquid can significantly improve the cure rate and clinical symptoms in patients with ulcerative colitis.